Tabuniag, Enorencio B.
HRN: 21-73-63 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/09/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
08/09/2022
08/15/2022
IV
1.5
Q12
Septic Arthritis
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: No Wrong Choice Wrong Choice
Overall appropriateness: No Wrong Choice